Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > We are STILL FRIKIN HALTED, WTF?

<< Previous

Bullboard Posts

Next >>

Post by ETalienon Feb 16, 2021 9:55am

298 Views

Post# 32572206

We are STILL FRIKIN HALTED, WTF?

There must be something else going on cause TSXV are in full control IIROC is in full control. There are companies that get halted everyday and unhalted! I know! So, the question is, what is Kalytera upto? What are they not doing and telling us that is giving us all super grief? Something really sticks now, this is taking far too long!
We should all call them relentlessly and demand to know what is going as investors!

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing